NASDAQ · PTHS

Pelthos Therapeutics Inc.

Healthcare · Biotechnology

$24.35

Down-$0.01 (-0.04%)

Updated Sep 6, 2026, 2:22 PM

SID Score

3.0/10

Composite research score

Smart Money

—

Institutional and insider signal

Market cap: 15.54M
P/E ratio: -3.11
Dividend yield: 0.00%
52-week range: $18.19 – $37.50
Volume: 18.8K
Avg. volume: 21.19K

Price performance

PTHS price history

1M range · 20 trading sessions · Daily adjusted prices

Last close: $24.35
Period change: -16.03%
Period low: $24.08
Period high: $29.00

Daily close

View OHLC price history

PTHS OHLC price history, latest 40 sessions
Date	Open	High	Low	Close	Volume
Sep 4, 2026	$24.44	$24.79	$24.01	$24.35	18.8K
Sep 3, 2026	$25.18	$25.60	$24.06	$24.36	43.48K
Sep 2, 2026	$24.59	$26.10	$23.26	$25.03	87.88K
Sep 1, 2026	$23.90	$24.825	$23.71	$24.82	18.86K
Aug 31, 2026	$24.16	$25.9151	$23.27	$24.08	79.24K
Aug 28, 2026	$24.605	$25.835	$24.00	$24.73	40.91K
Aug 27, 2026	$26.48	$27.08	$24.51	$25.00	83.49K
Aug 26, 2026	$27.07	$27.50	$26.31	$26.78	36.43K
Aug 25, 2026	$27.09	$28.1703	$25.97	$27.20	50.93K
Aug 24, 2026	$25.52	$27.23	$24.65	$26.62	151.27K
Aug 21, 2026	$26.41	$28.4731	$25.00	$25.51	21.64K
Aug 20, 2026	$26.03	$27.315	$25.86	$26.66	24.24K
Aug 19, 2026	$26.59	$28.135	$25.74	$25.82	17.79K
Aug 18, 2026	$25.69	$27.46	$25.69	$26.11	21.17K
Aug 17, 2026	$27.23	$28.055	$25.84	$25.90	29.26K
Aug 14, 2026	$28.00	$28.63	$26.97	$27.50	23.29K
Aug 13, 2026	$27.80	$29.80	$25.83	$28.95	44.12K
Aug 12, 2026	$28.84	$29.02	$28.02	$28.91	23.51K
Aug 11, 2026	$28.88	$29.08	$28.30	$28.63	37.82K
Aug 10, 2026	$28.20	$29.00	$28.20	$29.00	21.44K

Latest PTHS news

The latest Smart Investors Daily articles mentioning PTHS.

sec filingAug 19, 2026

Pelthos Therapeutics Inc. (PTHS) Files Proxy Statement Ahead of Shareholder Meeting

analystAug 17, 2026

Oppenheimer Reiterates Outperform Rating on Pelthos Therapeutics Inc. (PTHS)

sec filingAug 14, 2026

Pelthos Therapeutics Inc. (PTHS) Files Quarterly Report for Q0

Latest PTHS news

The latest Smart Investors Daily articles mentioning PTHS.

Stock researchResearch & News · SEC Filings

Company

Overview Forecast Earnings Dividend Financials

Market Activity

Options Insider Trades Short Interest Institutional Ownership Sentiment

Research & News

Analysis Competitors News SEC Filings SID Coverage

PTHS research

SEC Filings

Recent regulatory filings and source documents.

SEC filing history

Open a filing to view the original source document.

PTHS SEC filings
Filed	Form	Description	Accepted	Document
Aug 18, 2026	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Aug 13, 2026	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Aug 13, 2026	10-Q/A	Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]	—	Open source
Aug 13, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Aug 13, 2026	8-K	Form 8-K - Current report - Item 4.02	—	Open source
Jul 7, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jun 17, 2026	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Apr 14, 2026	8-K	Form 8-K - Current report - Item 7.01 Item 9.01	—	Open source
Apr 10, 2026	8-K	Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01	—	Open source
Mar 19, 2026	10-K	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	—	Open source
Mar 19, 2026	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Jan 13, 2026	8-K	Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 7.01 Item 9.01	—	Open source
Jan 12, 2026	8-K	Form 8-K - Current report - Item 5.02 Item 7.01	—	Open source
Jan 2, 2026	8-K	Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01	—	Open source
Dec 23, 2025	8-K	Form 8-K - Current report - Item 5.02 Item 8.01 Item 9.01	—	Open source
Dec 17, 2025	8-K	Form 8-K - Current report - Item 5.07	—	Open source
Nov 26, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Nov 25, 2025	DEF 14A	Form DEF 14A - Other definitive proxy statements	—	Open source
Nov 14, 2025	PRE 14A	Form PRE 14A - Other preliminary proxy statements	—	Open source
Nov 13, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Nov 13, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Nov 10, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Nov 7, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 8.01 Item 9.01	—	Open source
Oct 14, 2025	8-K	Form 8-K - Current report - Item 7.01	—	Open source
Sep 19, 2025	S-3/A	Form S-3/A - Registration statement under Securities Act of 1933: [Amend]	—	Open source
Sep 16, 2025	8-K/A	Form 8-K/A - Current report: [Amend] - Item 2.01 Item 2.02 Item 9.01	—	Open source
Sep 3, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 9.01	—	Open source
Aug 28, 2025	S-3	Form S-3 - Registration statement under Securities Act of 1933	—	Open source
Aug 18, 2025	8-K	Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01	—	Open source
Aug 13, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
Jul 25, 2025	S-8	Form S-8 - Securities to be offered to employees in employee benefit plans	—	Open source
Jul 23, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 21, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 7, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 3, 2025	4	Form 4 - Statement of changes in beneficial ownership of securities	—	Open source
Jul 2, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 2.01 Item 2.03 Item 3.02 Item 3.03 Item 5.01 Item 5.02 Item 5.03 Item 8.01 Item 9.01	—	Open source
May 13, 2025	10-Q	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	—	Open source
May 1, 2025	8-K	Form 8-K - Current report - Item 7.01 Item 9.01	—	Open source
Apr 17, 2025	8-K	Form 8-K - Current report - Item 1.01 Item 3.02 Item 4.01 Item 5.07 Item 7.01 Item 8.01 Item 9.01	—	Open source

Filed

Form

Description

Accepted

Document

Aug 18, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Aug 13, 2026

10-Q/A

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]

—

Open source

Aug 13, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Aug 13, 2026

8-K

Form 8-K - Current report - Item 4.02

—

Open source

Jul 7, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jun 17, 2026

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Apr 14, 2026

8-K

Form 8-K - Current report - Item 7.01 Item 9.01

—

Open source

Apr 10, 2026

8-K

Form 8-K - Current report - Item 5.02 Item 7.01 Item 9.01

—

Open source

Mar 19, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

—

Open source

Mar 19, 2026

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Jan 13, 2026

8-K

Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 7.01 Item 9.01

—

Open source

Jan 12, 2026

8-K

Form 8-K - Current report - Item 5.02 Item 7.01

—

Open source

Jan 2, 2026

8-K

Form 8-K - Current report - Item 1.01 Item 8.01 Item 9.01

—

Open source

Dec 23, 2025

8-K

Form 8-K - Current report - Item 5.02 Item 8.01 Item 9.01

—

Open source

Dec 17, 2025

8-K

Form 8-K - Current report - Item 5.07

—

Open source

Nov 26, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Nov 25, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

—

Open source

Nov 14, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

—

Open source

Nov 13, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Nov 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Nov 10, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Nov 7, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 2.03 Item 3.02 Item 8.01 Item 9.01

—

Open source

Oct 14, 2025

8-K

Form 8-K - Current report - Item 7.01

—

Open source

Sep 19, 2025

S-3/A

Form S-3/A - Registration statement under Securities Act of 1933: [Amend]

—

Open source

Sep 16, 2025

8-K/A

Form 8-K/A - Current report: [Amend] - Item 2.01 Item 2.02 Item 9.01

—

Open source

Sep 3, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 9.01

—

Open source

Aug 28, 2025

S-3

Form S-3 - Registration statement under Securities Act of 1933

—

Open source

Aug 18, 2025

8-K

Form 8-K - Current report - Item 2.02 Item 7.01 Item 9.01

—

Open source

Aug 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

Jul 25, 2025

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

—

Open source

Jul 23, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 21, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 7, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 3, 2025

Form 4 - Statement of changes in beneficial ownership of securities

—

Open source

Jul 2, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 2.01 Item 2.03 Item 3.02 Item 3.03 Item 5.01 Item 5.02 Item 5.03 Item 8.01 Item 9.01

—

Open source

May 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

—

Open source

May 1, 2025

8-K

Form 8-K - Current report - Item 7.01 Item 9.01

—

Open source

Apr 17, 2025

8-K

Form 8-K - Current report - Item 1.01 Item 3.02 Item 4.01 Item 5.07 Item 7.01 Item 8.01 Item 9.01

—

Open source

Pelthos Therapeutics Inc. (PTHS) Files Proxy Statement Ahead of Shareholder Meeting

Oppenheimer Reiterates Outperform Rating on Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. (PTHS) Files Quarterly Report for Q0

Featured By

Pelthos Therapeutics Inc. (PTHS) Files Proxy Statement Ahead of Shareholder Meeting

Oppenheimer Reiterates Outperform Rating on Pelthos Therapeutics Inc. (PTHS)

Pelthos Therapeutics Inc. (PTHS) Files Quarterly Report for Q0